T1	Participants 287 308	110 patients after LT
T2	Participants 438 450	all patients
T3	Participants 499 511	All patients
T4	Participants 933 977	Twenty-seven (48.2%) and 19 (35.2%) patients
T5	Participants 1057 1120	Two patients in the placebo group but none in the steroid group
